4Jamkhande PG, Chandak PG, Dhawale SC, et al. Therapeutic ap- proaches to drug targets in atherosclerosis[ J]. Saudi pharmaceu- tical journal: SPJ: the official publication of the Saudi Pharma- ceutical Society,2014,22 ( 3 ) : 179 - 90.
5Luo Y ,Jiang D ,Wen D ,et al. Changes in serum interleukin - 6 and high - sensitivity C - reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin [ J ]. Heart and vessels,2004,19(6) :257 -62.
6Hung MJ , Cherug WJ , Cheng CW , et al. Comparison of serum levels of inflammatory markers in patients with coronary vaso- spasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syn- dromes with significant fixed coronary artery disease [ J ]. The A- merican journal of cardiology ,2006,97 ( 10 ) : 1429 - 34.
7Rocchi E, Bursi F, Ventura P, et al. Anti - and pro - oxidant factors and endothelial dysfunction in chronic cigarette smokers with coronary heart disease [ J ]. European journal of internal medicine, 2007,18 (4) : 314 - 20.
8Arroyo - Espliguero R, Avanzas P, Quiles J, et al. C - reactive protein predicts functional status and correlates with left ventric- ular ejection fraction in patients with chronic stable angina[ J ]. Atherosclerosis ,2009,205 ( 1 ) : 319 - 24.
9Wang Y, Li L, Tan HW, et al. Transcoronary concentration gra- dient of sCIMOL and hsCRP in patients with coronary heart dis- ease[J]. Clinical cardiology 2007,30(2) :86 -91.
10Jones RD, Nettleship JE, Kapoor D, et al. Testosterone and ath- erosclerosis in aging men: purported association and clinical im- plications [ J ]. American journal of cardiovascular drugs: drugs, devices, and other interventions,2005,5 (3) : 141 - 54.
